CurrentRheuma coverage · page 16 of 48

Rheumatology (Oxford)

Briefs 601–640 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

Rheumatology (Oxford)2 Jun 2025
Lung transplantation outcomes of patients with interstitial pneumonia with autoimmune features: a single-centre retrospective cohort study
Cohort study
Rheumatology (Oxford)30 May 2025
Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink
Cohort studySystemic sclerosis
Rheumatology (Oxford)29 May 2025
An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP
Secondary analysisSystemic sclerosis
Rheumatology (Oxford)29 May 2025
Ankylosed posterior spinal structures: the catalyst for syndesmophytes growth and impaired spinal mobility in axial spondyloarthritis
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)29 May 2025
Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosus
Cohort studyLupus & APS
Rheumatology (Oxford)28 May 2025
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study
Cohort studyMyositis
Rheumatology (Oxford)27 May 2025
Risk of heart disease in neonates born to mothers with primary Sjögren’s syndrome: a multicenter retrospective study
Cohort studySjögren's & overlap
Rheumatology (Oxford)27 May 2025
DISH as a marker for incident diabetes mellitus in cardiovascular disease patients
Cohort study
Rheumatology (Oxford)27 May 2025
Clinical-imaging characteristics and management of anti-JO-1 and non-JO-1 anti-synthetase syndrome–associated interstitial lung disease
Cohort studyMyositis
Rheumatology (Oxford)26 May 2025
Association of physicians’ Big Five personality traits with shared decision-making in patients with SLE
Cross-sectional studyLupus & APS
Rheumatology (Oxford)24 May 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis
Cohort studyPediatric
Rheumatology (Oxford)24 May 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study
Cohort studyVasculitis & PMR
Rheumatology (Oxford)24 May 2025
Association between steatotic liver disease and risk of incident SSc: a nationwide cohort study
Cohort studySystemic sclerosis
Rheumatology (Oxford)24 May 2025
Pregnancy outcomes after maternal and paternal anti-IL-1 treatment exposure in cryopyrin-associated periodic syndromes (CAPS)
Cohort studyAutoinflammatory & rare
Rheumatology (Oxford)24 May 2025
Performance of the new PREVENT score for indicating subclinical atherosclerosis in rheumatoid arthritis
Diagnostic or prognostic studyRA
Rheumatology (Oxford)24 May 2025
Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial
Research articleVasculitis & PMR
Rheumatology (Oxford)24 May 2025
Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets
Mechanistic studyLupus & APS
Rheumatology (Oxford)23 May 2025
CRTAC1: a novel indicator of lung involvement in SSc
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)23 May 2025
Does body composition matter in patients with systemic sclerosis?
Cohort studySystemic sclerosis
Rheumatology (Oxford)23 May 2025
Continuous decline in Paget’s disease of bone: a One Health perspective on 2342 new diagnoses and their association with rural livestock
Cohort study
Rheumatology (Oxford)23 May 2025
The lack of association between cumulative MTX dose and liver fibrosis in PsA: a cohort study
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)23 May 2025
Characterization of fibroblast-like synoviocytes from the synovial fluid of patients affected by juvenile idiopathic arthritis
Mechanistic studyPediatric
Rheumatology (Oxford)23 May 2025
Exploring the impact of conventional and targeted DMARDs on body weight in patients with PsA
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)23 May 2025
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study
Cohort studyPediatric
Rheumatology (Oxford)21 May 2025
NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis
Cohort studyVasculitis & PMR
Rheumatology (Oxford)21 May 2025
The Fibrosis-4 Index (FIB-4) correlates with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis
Cross-sectional studyRA
Rheumatology (Oxford)21 May 2025
Meta-analysis revealed HLA susceptibility markers in ANCA-associated vasculitis and its clinical subtypes
Meta-analysisVasculitis & PMR
Rheumatology (Oxford)21 May 2025
Functional brain networks related to processing speed and memory in SLE: a connectome-based modelling study
Cross-sectional studyLupus & APS
Rheumatology (Oxford)20 May 2025
Psoriatic arthritis flare incidence, definition and risk factors: a systematic review
Meta-analysisSpondyloarthritis & PsA
Rheumatology (Oxford)19 May 2025
Association of clinical and sonographic factors with discrepancy between patients’ and evaluators’ global assessments in psoriatic arthritis
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)19 May 2025
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)15 May 2025
Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus
Cohort studyLupus & APS
Rheumatology (Oxford)15 May 2025
Single-cell transcriptome analysis profiles cellular and molecular alterations in aortic tissue from patients with Behçet’s syndrome
Mechanistic studyVasculitis & PMR
Rheumatology (Oxford)14 May 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure
Cohort studyVasculitis & PMR
Rheumatology (Oxford)13 May 2025
Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from the FIRST registry
Cohort studyRA
Rheumatology (Oxford)13 May 2025
Efficacy and safety of ultrasound-guided needle muscle biopsy in the diagnosis of idiopathic inflammatory myopathies
Cohort studyMyositis
Rheumatology (Oxford)13 May 2025
Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study
Cohort studyLupus & APS
Rheumatology (Oxford)12 May 2025
The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance
Cohort studySystemic sclerosis
Rheumatology (Oxford)10 May 2025
The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study
Cohort studyMyositis
Rheumatology (Oxford)9 May 2025
Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry
Cohort studyVasculitis & PMR

All 1,905 Briefs in ExploreShowing Briefs 601–640 of 1,905, newest first